reglab/statecodes huggingface dataset:
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › POST-RACE TESTING › Section 401.26 - Packaging and shipping of split samples

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The Commission or its investigative staff
					 shall be responsible for the packaging and shipping of the split sample and
					 shall coordinate the time and location for the packaging of the split sample at
					 the test barn with the owner, trainer or representative. The owner or trainer
					 requesting testing of a split sample shall be responsible for the cost of the
					 testing, including the cost of shipping.
(b) Failure of the owner, trainer or a
					 designee to appear at the time and place designated by the Commission
					 representative in connection with packaging and shipping the split sample shall
					 constitute a waiver of any right to challenge Commission's
					 procedures.
(c) Prior to opening
					 the split sample freezer or refrigerator, the Commission's representative shall
					 provide the split sample verification form or split sample packaging form or
					 any other similar form approved by the Commission. The forms shall be completed
					 fully during the retrieval, packaging and shipment of the split sample and
					 shall contain the following information:
(1)
					 The date and time the sample is removed from the split sample
					 freezer;
(2) The sample
					 number;
(3) The address where the
					 split sample is to be sent; and,
(4) A check from the owner or trainer made
					 payable to the split sample laboratory with the appropriate testing
					 fee.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › POST-RACE TESTING › Section 401.27 - Frozen samples

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The
					 Commission from time to time may direct the Commission Testing Laboratory to
					 retain and preserve by freezing samples for future analysis or research
					 purposes.
(b) After 1 year from the
					 date of sampling, the Commission may grant permission, at the request of the
					 Commission Testing Laboratory, to properly dispose of primary samples which
					 were determined to contain no prohibited substances or in the case of samples
					 which were determined as positive, after all administrative appeals have been
					 exhausted.
(c) The distribution of
					 purse money prior to the issuance of a final laboratory report shall not be
					 considered a finding that no prohibited drug, medication, substance or
					 metabolic derivative has been administered to a horse.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › POST-RACE TESTING › Section 401.28 - Commission Testing Laboratory minimum standards

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The purpose of the Commission Testing
					 Laboratory is to analyze biologic samples for the presence in race horses of
					 any drugs, medications, foreign substances or other substances including
					 permitted medications in excess of the maximum allowable levels and to reports
					 those findings to the Standardbred and Thoroughbred Horse Racing Bureau
					 Directors.
(b) The Commission
					 Testing Laboratory shall at all times continue to meet and maintain the minimum
					 competency standards as set forth by National and International accrediting
					 bodies such as the American Association of Laboratory Accreditation (A2LA) and
					 the RMTC or other similar accrediting bodies under the globally recognized
					 ISO/IEC 17025
General Requirements for the Competence of Testing and
					 Calibration Laboratories
.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › POST-RACE TESTING › Section 401.29 - Split sample testing laboratory minimum standards

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The designated split sample testing
					 laboratory (Split Lab) conducting split post-race sample analysis must, at a
					 minimum, demonstrate technical competence in the field of chemical testing and
					 laboratory quality management be meeting similar accreditation standards and
					 testing standards as the Commission Testing Laboratory.
(b) The Commission shall provide a list of
					 approved split sample laboratories for use.
This section cited in 7 Pa. Code §
													401.25 (relating to storage of
						  split samples).
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › UNIFORM MEDICATION CLASSIFICATION AND PENALTIES › Section 401.42 - Uniform classification guidelines for foreign substances

Current through Register Vol. 54, No. 28, July 13, 2024
The Commission adopts the following outline which
						describes the types of medications, drugs and substances placed in each
						classification. This list shall be publicly posted on the Commission's web
						site, in the offices of the Commission Veterinarian and in the office of the
						racing secretary.
(1)
Class
					 1
:
Opiates, opium derivatives, synthetic opioids,
						psychoactive drugs, amphetamines, all United States Drug Enforcement Agency
						Schedule I drugs and many Schedule II drugs. Also found in this class are drugs
						that are potent stimulants of the central nervous system. Drugs in this class
						have no generally accepted medical use in the racing horse and their
						pharmacologic potential for altering the performance of a racing horse is very
						high.
(2)
Class
					 2
:
Drugs placed in this classification have a high potential
						for affecting the outcome of a race. Most are not generally accepted as
						therapeutic agents in the racing horse. Many are products intended to alter
						consciousness or the psychic state of humans and have no approved or indicated
						use in the horse. Some, such as injectable local anesthetics, have legitimate
						use in equine medicine, but should not be found in a racing horse. The
						following groups of drugs placed are in this class:
(i) Opiate partial agonists or
					 agonist-antagonists;
(ii)
					 Non-opiate psychotropic drugs. These drugs may have stimulant, depressant,
					 analgesic or neuroleptic effects;
(iii) Miscellaneous drugs which might have a
					 stimulant effect on the central nervous system (CNS);
(iv) Drugs with prominent CNS depressant
					 action;
(v) Antidepressant and
					 antipsychotic drugs, with or without prominent CNS stimulatory or depressant
					 effects;
(vi) Muscle blocking drugs
					 that have a direct neuromuscular blocking action;
(vii) Local anesthetics that have a
					 reasonable potential for use as nerve blocking agents (except procaine);
					 and
(viii) Snake venoms and other
					 biologic substances, which may be used as nerve blocking agents.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › UNIFORM MEDICATION CLASSIFICATION AND PENALTIES › Section 401.43 - Positive test penalty categories

Current through Register Vol. 54, No. 28, July 13, 2024
(a) To maintain consistency of drug
					 medication penalties with surrounding racing jurisdictions, in accordance with
					 section 9312(6) of the act (relating to additional powers of commission), the
					 Commission shall adopt and publish in the
Pennsylvania
					 Bulletin
The most recent version of the "Penalty Categories" set forth
					 in the
Uniform Classification Guidelines of Foreign Substances
as established by ARCI. The penalty categories "A", "B", "C" and "D" and their
					 related schedules for trainers and owners shall also contain provisions for the
					 number of offenses committed which shall determine the level of penalty
					 assessed.
(b) The Commission,
					 Bureau Directors, Judges or the Stewards may use the penalty "categories" and
					 medication guidelines schedule as a starting place in the penalty stage of the
					 deliberations for a violation of the Commission's medication and foreign
					 substance rules.
(c) In issuing
					 penalties against individuals found guilty of medication and drug violations, a
					 regulatory distinction may be made between the detection of therapeutic
					 medications used routinely to treat racehorses and those drugs that have no
					 reason to be found at any concentration in the test sample on race
					 day.
(d) If a licensed veterinarian
					 is administering or prescribing a drug not listed in the ARCI
Uniform
					 Classification Guidelines for Foreign Substances
, the identity of the
					 drug shall be forwarded to the Commission Testing Laboratory for
					 classification.
(e) A drug or
					 metabolite thereof found to be present in a pre-race or post-race sample which
					 is not classified in the most current ARCI
Uniform Classification
					 Guidelines for Foreign Substances
shall be deemed Class 1 drug and the
					 trainer and/or owner shall be subject to those penalties as set forth in
					 schedule "A."
(f) The recommended
					 penalty for a violation involving a drug that carries a Category "D" penalty is
					 a written warning to the trainer and owner. Multiple violations may result in
					 fines or suspensions, or both.
(g)
					 A licensee of the Commission, including practicing veterinarians, found to be
					 responsible for the improper or intentional administration of any drug
					 resulting in a positive test may, after proper notice and hearing, be subject
					 to the same penalties set forth for the licensed trainer.
This section cited in 7 Pa. Code §
													401.41 (relating to determination
						  of positive test results).
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › UNIFORM MEDICATION CLASSIFICATION AND PENALTIES › Section 401.44 - Criminal or administrative licensing referrals

Current through Register Vol. 54, No. 28, July 13, 2024
(a) In addition to any penalties issued by
					 the Judges, Stewards or the Commission, a veterinarian found to be involved in
					 the administration of any drug carrying the penalty category of "A" shall be
					 referred to the State Board of Veterinary Medicine for consideration of further
					 disciplinary action or license revocation.
(b) In accordance with the provisions of the
					 act, a person believed to have committed acts in violation of Pennsylvania
					 criminal statutes may be referred to the appropriate law enforcement agency.
					 Administrative action taken by the Judges, Stewards or the Commission shall not
					 prohibit a prosecution for criminal acts committed, nor shall a criminal
					 prosecution preclude the administrative action by the Judges, Stewards or the
					 Commission.
(c) Procedures shall be
					 established to ensure that a licensed trainer is not able to benefit
					 financially during the period for which the individual has been suspended. This
					 shall include ensuring that horses are not transferred to licensed family
					 members or employees of the suspended person.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › UNIFORM MEDICATION CLASSIFICATION AND PENALTIES › Section 401.45 - Responsibility of a trainer

Current through Register Vol. 54, No. 28, July 13, 2024
As fully set forth in Chapters 205 and 305 (relating to
						rules of Standardbred racing-temporary regulations; and rules of Thoroughbred
						racing-temporary regulations), a trainer shall be responsible for the condition
						of the horses in the care, custody or control of the trainer regardless of the
						trainer's physical location.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › UNIFORM MEDICATION CLASSIFICATION AND PENALTIES › Section 401.46 - Control of horse, presumption of knowledge

Current through Register Vol. 54, No. 28, July 13, 2024
Whenever the chemical analysis test described in this
						chapter discloses the presence of a drug, stimulant, depressant or foreign
						substance or therapeutic medications above the established levels, it shall be
						presumed that the same was administered by the person having the care, custody
						or control of the horse and that the administering was done with the intent to
						affect the speed or condition of the horse and the result of the race in which
						it participated.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › UNIFORM MEDICATION CLASSIFICATION AND PENALTIES › Section 401.47 - Persons found guilty of administration of drugs

Current through Register Vol. 54, No. 28, July 13, 2024
A person found guilty by the Commission of participation
						in or knowledge that a narcotic, stimulant or similar illegal drug has been
						administered to a horse shall be summarily ruled off from all tracks in this
						Commonwealth and upon notice and hearing, the occupational license may be
						revoked.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › MULTIPLE MEDICATION VIOLATION POINT SYSTEM › Section 401.51 - Multiple medication violation points

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A trainer, who receives a penalty for a
					 medication violation based upon a horse testing positive for a Class 1-5
					 medication with a Category A-C penalty, as provided in the most recent version
					 of the ARCI
Uniform Classification Guidelines for Foreign
					 Substances
, or similar state regulatory guidelines, shall be assigned
					 additional multiple medication violation (MMV) enhanced points as follows:
Penalty Class
Points If Controlled Therapeutic Substance
Points If Non-Controlled Substance
Class A
N/A
6
Class B
2
4
Class C
1/2 for first violation with an
								  additional 1/2 point for each additional violation within 365
								  days1
1 for first violation with an
								  additional 1/2 point for each additional violation within 365 days
Class D
0
0
1 Points for NSAID violations
						only apply when the primary threshold of the NSAID is exceeded. Points are not
						to be separately assigned for a stacking violation.
(1) If the Standardbred or Thoroughbred Horse
					 Racing Bureau Directors, or Judges and Stewards determine that the violation is
					 due to environmental contamination, they may assign lesser or no points against
					 the trainer based upon the specific facts of the case.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › MULTIPLE MEDICATION VIOLATION POINT SYSTEM › Section 401.52 - Enhancement points

Current through Register Vol. 54, No. 28, July 13, 2024
(a) In addition
					 to the penalty for the underlying offense, the following enhancements shall be
					 imposed upon a licensed trainer based upon the cumulative points contained in
					 his/her official ARCI record:
Points
Suspension in days
5-5.5
15 to 30
6-8.5
30 to 60
9-10.5
90 to 180
11 or more
180 to 360
(b) MMV penalties are not a substitute for
					 the current penalty system and are intended to be an additional uniform penalty
					 when the licensee:
(i) Has had more than one
					 medication violation for the relevant time period; and
(ii) Exceeds the permissible number of
					 points.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › MULTIPLE MEDICATION VIOLATION POINT SYSTEM › Section 401.53 - Expiration of points

Current through Register Vol. 54, No. 28, July 13, 2024
(a) Points
					 shall expire as follows:
Penalty Classification
Time to Expire
A
3 years
B
2 years
C
1 year
(b) In the case of a medication violation
					 that results in a suspension, any points assessed expire on the anniversary
					 date of the date the suspension is completed.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › OTHER PROHIBITED CONDUCT › Section 401.61 - Possession of hypodermic needles, syringes and injectable substances

Current through Register Vol. 54, No. 28, July 13, 2024
No person, except a Commission Veterinarian, racetrack
						veterinarian or veterinarian licensed by the Commission, may possess or use a
						hypodermic needle, hypodermic syringe capable of accepting a needle and
						injectable substances of any kind, type or description on the licensed
						racetrack grounds, in that person's custody, control or possession. If a person
						has a medical condition which makes it necessary to have a syringe while on the
						grounds of a racetrack, that person must request permission of the Judges or
						Stewards in writing, furnish a letter form a licensed physician explaining the
						necessity of the syringe and must comply with any conditions or restrictions
						set by the Judges or Stewards. Violations of this rule will subject the
						violator to a fine, suspension or both.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 401 - PROHIBITED AND UNLAWFUL PRACTICES-TEMPORARY REGULATIONS › OTHER PROHIBITED CONDUCT › Section 401.62 - Mistreatment of horses

Current through Register Vol. 54, No. 28, July 13, 2024
A licensee or other person under the jurisdiction of the
						Commission may not alone or in concert with another person permit an animal
						under his control to be subjected to a form of cruelty, mistreatment, neglect
						or abuse or abandon, or to injure, maim or kill or administer a noxious or
						harmful substance to or deprive an animal of necessary care, sustenance,
						shelter or veterinary care.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.1 - General purpose

Current through Register Vol. 54, No. 28, July 13, 2024
To expressly set forth the professional duties, ethical
					 obligations and procedures to be used by licensed equine veterinarians to
					 ensure the health, safety and welfare of racehorses and to properly safeguard
					 the integrity of racing, the interests of the general public and the
					 participants in racing. In addition to the licensing requirements under Chapter
					 185 (relating to occupational licenses-temporary regulations) and §
										§
										303.71-303.73 (relating to practicing
					 veterinarians) of the Commission's regulations, practicing veterinarians shall
					 comply with the following provisions and requirements of this chapter and with
					 their professional duties and ethical obligations under their veterinary
					 license.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.2 - Role of practicing veterinarians

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
				  Veterinarians licensed by the Commission and practicing at any licensed racing
				  facility under the jurisdiction of the Commission are under the authority of
				  the Commission Veterinarian and the Board of Judges or Board of Stewards at
				  that facility or other location.
(b) The following limitations apply to drug
				  treatments of horses that are engaged in racing activities, including training,
				  related to competing in pari-mutuel racing in this Commonwealth:
(1) No drug or other substance may be
				  administered except in the context of a valid veterinarian-client-patient
				  relationship between the attending veterinarian, the horse owner (who may be
				  represented by the trainer or other agent) and the horse.
(2) The owner is not required by this
				  subdivision to follow the veterinarian's instructions, but no drug may be
				  administered without a veterinarian having examined the horse and provided the
				  treatment recommendation. This relationship requires the following:
(i) The veterinarian, with the consent of the
				  owner, has accepted responsibility for making medical judgments about the
				  health of the horse;
(ii) The
				  veterinarian has sufficient knowledge of the horse to make a preliminary
				  diagnosis of the medical condition of the horse;
(iii) The veterinarian has performed an
				  examination of the horse and is acquainted with the keeping and care of the
				  horse;
(iv) The veterinarian is
				  available to evaluate and oversee treatment outcomes, or has made appropriate
				  arrangements for continuing care and treatment;
(v) The relationship is maintained by
				  veterinary visits as needed;
(vi)
				  The veterinarian's judgment is independent and not dictated by the trainer or
				  owner of the horse; and,
(vii) The
				  veterinarian maintains appropriate, substantial and pertinent records
				  reflecting the treatment of the horses as previously set forth.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.3 - Treatment restrictions

Current through Register Vol. 54, No. 28, July 13, 2024
(a) Only
				  licensed owners or trainers shall be permitted to authorize veterinary medical
				  treatment of horses under the veterinarian's care, custody and control at a
				  racetrack, licensed facility or other location under the jurisdiction of the
				  commission.
(b) Except as otherwise
				  provided by this subsection, no person other than a veterinarian licensed to
				  practice veterinary medicine in this jurisdiction and licensed by the
				  Commission may administer a prescription or controlled medication, drug,
				  chemical or other substance (including any medication, drug, chemical or other
				  substance by injection) to a horse at any racetrack, facility or other location
				  under the jurisdiction of the Commission.
(c) This subsection does not apply to the
				  administration of the following substances except in approved quantitative
				  levels, if any, present in post-race samples or as they may interfere with
				  post-race testing:
(1) A recognized
				  non-injectable nutritional supplement or other substance approved by the
				  official veterinarian;
(2) A
				  non-injectable substance on the direction or by prescription of a licensed
				  veterinarian; or
(3) A
				  non-injectable non-prescription medication or substance.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.4 - Treatment sheets or veterinarian medication report forms

Current through Register Vol. 54, No. 28, July 13, 2024
(a) Every
				  veterinarian who treats a racehorse at any racetrack or other location under
				  the jurisdiction of the Commission shall maintain an accurate and complete
				  written log of treatment activities on a Medication Report Form or Treatment
				  Sheet and report the treatment to the Commission office, the Stewards or Judges
				  at the racetrack where the horse is entered to run or as otherwise specified by
				  the Commission. The Treatment Sheet shall contain the following:
(1) The name of the horse treated;
(2) List of all medications, drugs,
				  substances, or procedures administered or prescribed to the horse;
(3) The name of the trainer of the
				  horse;
(4) The date and time of
				  treatment;
(5) Indicate the route
				  of administration on all meds and specific amounts administered; must list all
				  oral medications left with trainers and indicate the horse's need for these
				  oral medications;
(6) For all
				  intra-articular injections, identify the exact location, body part, limb or
				  joint on the horse of the injection and specific dosage amounts;
(7) Indicate whether the horse is entered to
				  run; and
(8) Any other information
				  that may be requested by the Commission veterinarian.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.5 - Prohibited substances and methods

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The
				  substances and methods listed in the Commission's Prohibited Substances List in
				  §
										403.9 (relating to prohibited
				  substances list) may not be used at any place or time and may not be possessed
				  on the premises of a licensed racetrack, licensed facility or other location
				  under the jurisdiction of the Commission, except as a restricted therapeutic
				  use. As the Prohibited Substances List is amended, the Commission shall publish
				  the most recent version of the list in the
Pennsylvania
				  Bulletin
and on its web site.
(b)
Restricted Therapeutic
				  Use
. A limited number of medications on the Prohibited Substance List
				  shall be exempted when the administration occurs in compliance with the
				  Required Conditions for Restricted Therapeutic Use chart set forth in §
										403.11 (relating to restricted
				  therapeutic use requirements chart):
(1)
Report When Sampled
means the administration of the substance
				  must be reported to the Commission when the horse is next sampled, if the horse
				  is sampled within 24 hours after the administration;
(2)
Pre-File Treatment Plan
means a treatment plan for the substance which must be filed by the time of
				  administration in a manner approved by the Commission;
(3)
Written Approval from
				  Commission
means the Commission has granted written approval of a
				  written treatment plan before the administration of the substance;
(4)
Emergency Use (report)
means the substance had to be administered due to an acute emergency involving
				  the life or health of the horse, provided the emergency use is reported to the
				  Commission as soon as practicable after the treatment occurs;
(5)
Prescribed by
				  Veterinarian
means the substance has been prescribed by an attending
				  veterinarian, in compliance with this chapter and recorded in the veterinary
				  records in the manner required by the Commission;
(6)
Report Treatment
means
				  the treatment must be reported to the Commission by the trainer at the time of
				  administration to provide the Commission with information for the
				  Veterinarian's List. The trainer may delegate this responsibility to the
				  treating veterinarian, who shall make the report to the Commission when so
				  designated; and
(7)
Other
				  Limitations
means additional requirements that apply, such as a
				  substance may be used in only fillies or mares or a horse that is administered
				  a substance shall be reported immediately to the Commission and placed on the
				  Veterinarian's List for a specific minimum period of time.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.6 - Blood doping substances or agents prohibited

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The
				  possession or use, or both, of the following substances or of blood doping
				  agents, including but not limited to those listed as follows, on the racetrack
				  premises or other facility under the jurisdiction of the Commission is
				  expressly forbidden:
(1) Aminoimidazole
				  carboxamide ribonucleotide (AICAR);
(2) Darbepoetin;
(3) Equine Growth Hormone;
(4) Erythropoietin;
(5) Hemopure®;
(6) Myo-Inositol Trispyprophosphate
				  (ITPP);
(7)
				  Oxyglobin®;
(8) Thymosin
				  beta;
(9) Venoms or derivatives
				  thereof; and
(10) Thymosin
				  beta.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.7 - Extracorporeal shock wave therapy or radial pulse wave therapy

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The use of
				  Extracorporeal Shock Wave Therapy or Radial Pulse Wave Therapy ("shock wave
				  therapy") or other acoustic wave high energy, high amplitude devices,
				  therapies, treatments or similar mechanisms, devices or treatments shall not be
				  permitted unless the following conditions are satisfied:
(1) Only licensed veterinarians are permitted
				  to use the prereferenced types of Extracorporeal shock wave devices or perform
				  therapies and treatments on a horse as previously defined;
(2) Only licensed veterinarians are permitted
				  to possess or use any instrument used to administer or deliver shock wave
				  therapy on the licensed racetrack grounds or other facility under the
				  jurisdiction of the Commission;
(3)
				  All shock wave therapy machines or devises, whether in operating condition or
				  not, must be registered with and approved by the Commission or its designee
				  before the machine is brought to or possessed on any racetrack or other
				  facility under the jurisdiction of the Commission;
(4) All shock wave therapy machines must be
				  reported and registered within 24 hours prior to treatment on the prescribed
				  form to the Commission veterinarian.
(5) All shock wave therapy machines must be
				  used at a previously-disclosed location that is approved by the Commission.
				  Commission investigative staff shall be granted access to any location housing
				  a registered shock wave therapy machine of any type.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.8 - Nasogastric tube

Current through Register Vol. 54, No. 28, July 13, 2024
The use of a nasogastric tube (a tube longer than 6 inches)
					 for the administration of any substance within 24 hours prior to the post time
					 of the race in which the horse is entered is prohibited, unless performed by a
					 licensed practicing veterinarian and properly logged in a medical
					 report/treatment sheet in accordance with this chapter.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.9 - Prohibited substances list

Current through Register Vol. 54, No. 28, July 13, 2024
(a) All
				  substances in the following categories of drugs shall be strictly prohibited,
				  unless otherwise exempted by the Commission in accordance with the provisions
				  of this chapter: non-approved substances; anabolic agents/steroids; growth
				  hormones; hormone and metabolic modulators; diuretics and other masking agents.
				  The Prohibited Substance List is a comprehensive list of those prohibited
				  substances. Since the Prohibited Substance List, as established by the ARCI is
				  subject to frequent review, amendment or modification, the Commission shall
				  annually notify the regulated community and publish the Prohibited Substance
				  List in the
Pennsylvania Bulletin
and on its web
				  site.
(b) In accordance with
				  section 9312(6) (relating to additional powers of commission) of the act, the
				  Commission is authorized to adopt National standards relating to prohibited
				  substances, uniform drug thresholds or penalties, which includes the Prohibited
				  Substance List, as established or amended by other racing jurisdictions or
				  commission-recognized National regulatory racing organizations, such as ARCI or
				  the USTA.
This section cited in 7 Pa. Code §
												403.5 (relating to prohibited
						substances and methods).
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.10 - Prohibited manipulation of blood and blood components

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The
				  following conduct or manipulation is expressly prohibited:
(1) The administration or reintroduction of
				  any quantity of autologous, allogenic (homologous) or heterologous blood or red
				  blood cell products of any origin into the circulatory system.
(2) Artificially enhancing the uptake,
				  transport or delivery of oxygen, including, but not limited to,
				  perfluorochemicals, efaproxiral (RSR13) and modified hemoglobin products (for
				  example hemoglobin-based blood substitutes, microencapsulated hemoglobin
				  products), excluding supplemental oxygen.
(3) Any form of intravascular manipulation of
				  the blood or blood components by physical or chemical means.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.11 - Restricted therapeutic use requirements chart

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The
				  Commission hereby adopts the ARCI Restricted Therapeutic Use Requirements Chart
				  (Chart) which is intended to provide the treating veterinarian with specific
				  conditions and approvals for the therapeutic use of what are normally
				  restricted or prohibited substances. The Chart identifies the particular
				  prohibited substance and whether the veterinarian must prefile the treatment
				  plan with the Commission and which substances require written approval from the
				  Commission. The Chart provides for instances of emergency use of prohibited
				  substances as prescribed by the treating veterinarian.
(b) In accordance with section 9312(6)
				  (relating to additional powers of commission) of the act, the Commission is
				  authorized to adopt National standards relating to prohibited substances,
				  uniform drug thresholds or penalties, which includes the Chart, as established
				  or amended by other racing jurisdictions or Commission-recognized National
				  regulatory racing organizations, such as ARCI or the USTA. The Commission shall
				  provide notice to the regulated community and publish the Chart in the
Pennsylvania Bulletin
and on the Commission's web
				  site.
This section cited in 7 Pa. Code §
												403.5 (relating to prohibited
						substances and methods).
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.12 - Medical labeling

Current through Register Vol. 54, No. 28, July 13, 2024
(a) While on
				  racetrack grounds and facilities, no person shall have or be in possession of a
				  drug, medication, chemical, foreign substance or other substance that is
				  prohibited in a horse on a race day, unless the product is labeled in
				  accordance with this subsection. Possession shall be deemed to include any
				  location in and upon the racetrack grounds which that person occupies or has
				  the right to occupy or is in that person's personal property or effects or in
				  any vehicle in that person's care, custody or control.
(b) All allowable medications must have a
				  prescription label which is securely attached to the medication container and
				  clearly ascribed to show the following:
(1)
				  Name, address and telephone number of the pharmacy or veterinarian dispensing
				  the medication;
(2) Prescription
				  number when dispensed by a pharmacy if required by law;
(3) Date prescription filled;
(4) Name of the prescribing
				  veterinarian;
(5) Name of the horse
				  for whom the medication is prescribed or dispensed;
(6) Name of the trainer or owner of the horse
				  for whom the product was dispensed;
(7) Dose, dosage, route of administration,
				  and duration of treatment of the prescribed product (instructions for
				  use);
(8) Name, active ingredient,
				  quantity prescribed, expiration date (if applicable), beyond use date (if
				  applicable), and lot number (if applicable); and
(9) Cautionary statements (if any), and if
				  applicable, withdrawal time.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.13 - Non-steroidal anti-inflammatory drugs

Current through Register Vol. 54, No. 28, July 13, 2024
The use of Non-Steroidal Anti-Inflammatory drugs (NSAID)
					 shall be governed by the following conditions:
(a) NSAIDs included in the Commission's
				  annually approved Controlled Therapeutic Medication List are not to be used in
				  a manner inconsistent with the restrictions contained therein. NSAIDs not
				  included on the Commission's Controlled Therapeutic Medication List are not to
				  be present in a racing horse biological test sample at the laboratory
				  concentration of detection.
(b) The
				  presence of more than one NSAID may constitute a NSAID stacking violation
				  consistent with the following restrictions:
(1) A Class 1 NSAID Stacking Violation
				  (Penalty Class B) occurs when:
(i) Two
				  Non-Steroidal Anti-Inflammatory drugs are found at individual levels determined
				  to exceed the following restrictions:
(a)
				  Diclofenac-5 nanograms per milliliter of plasma or serum;
(b) Firocoxib-20 nanograms per milliliter of
				  plasma or serum;
(c) Flunixin-20
				  nanograms per milliliter of plasma or serum;
(d) Ketoprofen-2 nanograms per milliliter of
				  plasma or serum;
(e)
				  Phenylbutazone-2 micrograms per milliliter of plasma or serum; or
(f) All other Non-Steroidal Anti-Inflammatory
				  drugs-laboratory concentration of detection.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.14 - Furosemide (Lasix-Thoroughbred)

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The
				  Commission recognizes that the diuretic Furosemide (Lasix) is helpful in the
				  management of Exercise Induced Pulmonary Hemorrhage (EIPH). In regulating the
				  race-day use of Furosemide (Lasix), the Commission has placed strict controls
				  on the dose, route and time the medication is administered. All of these
				  measures are designed to provide a thorough regulation of Furosemide (Lasix)
				  and prevent the misuse of the drug.
(b) A horse is eligible to race with
				  Furosemide (Lasix) if at least one of the following occurs:
(1) The horse is on the Commission's
				  Furosemide (Lasix) list and has complied with the provisions of subsection
				  (c);
(2) The horse is on the
				  Commission's Bleeder List and has complied with the provisions of subsection
				  (d);
(3) The trainer provides the
				  Commission Veterinarian or the designee with evidence that the horse in on the
				  Furosemide (Lasix) list or the Bleeder List in another jurisdiction. Acceptable
				  evidence shall be a Furosemide or bleeder certificate approved by that
				  jurisdiction's official veterinarian.
(4) The trainer provides the Commission
				  Veterinarian or the designee with evidence that the horse has been running
				  consistently, up to the last start, with Furosemide (Lasix) in other racing
				  jurisdictions as shown on official past performance records from Equibase or
				  Racing Form.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.15 - Furosemide (Lasix-Standardbred)

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The
				  Commission recognizes that the diuretic Furosemide (Lasix) is helpful in the
				  management of Exercise Induced Pulmonary Hemorrhage (EIPH) in the Standardbred
				  horse. Accordingly, 2-year-old harness horses or older shall be eligible for
				  bleeder medication as set forth below. In regulating the race-day use of
				  Furosemide (Lasix), the Commission has placed strict controls on the dose,
				  route and time the medication is administered. All of these measures are
				  designed to provide a thorough regulation of Furosemide (Lasix) and prevent the
				  misuse of the drug.
(b) A horse is
				  eligible to race with Furosemide (Lasix) if at least one of the following
				  occurs:
(1) The horse is on the Commission's
				  bleeder's list and the Judge's list in accordance with the following
				  provisions;
(2) The trainer
				  provides the Commission Veterinarian or the designee with evidence that the
				  horse in on the Furosemide (Lasix) list or the bleeder list in another
				  jurisdiction. Acceptable evidence shall be a Furosemide (Lasix) or bleeder
				  certificate approved by that jurisdiction's official veterinarian.
(3) The trainer provides the Commission
				  Veterinarian or the designee with evidence that the horse has been running
				  consistently, up to the last start, with Furosemide (Lasix) in other racing
				  jurisdictions as shown on official past performance records from the USTA,
				  Equibase or the Racing Form.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.16 - Environmental contaminants and substances of human use

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
				  Environmental contaminants are either endogenous to the horse or can arise from
				  plants traditionally grazed or harvested as equine feed or are present in
				  equine feed because of contamination during the cultivation, processing,
				  treatment, storage or transportation phases.
(b) Substances of human use and addiction may
				  be found in the horse due to its close association with humans.
(c) If probative and substantial evidence is
				  presented to the Bureau Directors prior to a hearing or presented to the Judges
				  or Stewards during a hearing which indicates that a positive test may have been
				  a result of environmental contamination, including inadvertent exposure due to
				  human drug use, or dietary intake, or is endogenous to the horse, those factors
				  may be considered in mitigation of any disciplinary action taken against the
				  affected trainer.
Pennsylvania Code › Title 7 - AGRICULTURE › Part VIII - State Horse Racing Commission › Subpart F - Foreign Substances, Medications, Drugs and Equine Veterinary Practices › Chapter 403 - EQUINE VETERINARY PRACTICES-TEMPORARY REGULATIONS › Section 403.17 - Androgenic-anabolic steroid (AAS)

Current through Register Vol. 54, No. 28, July 13, 2024
(a) As set
				  forth in the Commission's regulations, no Androgenic-anabolic steroid (AAS)
				  shall be permitted in test samples collected from racing horses except for
				  endogenous concentrations of the naturally occurring substances boldenone,
				  nandrolone and testosterone at concentrations less than the approved
				  thresholds.
(b) Concentrations of
				  these AAS shall not exceed the following free (that is, not conjugated) steroid
				  concentrations in plasma or serum:
(1)
Boldenone
-A confirmatory threshold not greater than 25
				  picograms/milliliter for all horses, regardless of sex;
(2)
Nandrolone
-A
				  confirmatory threshold not greater than 25 picograms/milliliter for fillies,
				  mares and geldings; male horses other than geldings shall be tested for
				  Nandrolone in urine;
(3)
Testosterone
-A confirmatory threshold not greater than 100
				  picograms/milliliter for fillies, mares and gelding.